Bionano announces closing of $10 million registered direct offering priced at-the-market under nasdaq rules

San diego, jan. 06, 2025 (globe newswire) -- bionano genomics, inc. (nasdaq: bngo) today announced the closing of its previously announced registered direct offering priced at-the-market under nasdaq rules for the purchase and sale of an aggregate of 39,682,540 shares of its common stock (or common stock equivalents) and warrants to purchase up to an aggregate of 39,682,540 shares of common stock (the “warrants”), at a combined offering price of $0.252 per share of common stock (or per common stock equivalent) and accompanying warrant. the warrants have an exercise price of $0.252 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares of common stock upon exercise of the warrants (the “stockholder approval”).
BNGO Ratings Summary
BNGO Quant Ranking